Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas

The long-term prognosis after surgical resection of malignant insulinoma (INS) is poor. Novel adjuvant therapies, specifically targeting cancer stem cells (CSCs), are warranted. Therefore, the goal of this study was to characterize and target putative INS CSCs. Using fluorescence-activated cell sort...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cells Dev
Autori principali: Buishand, Floryne O., Arkesteijn, Ger J.A., Feenstra, Laurien R., Oorsprong, Claire W.D., Mestemaker, Margiet, Starke, Achim, Speel, Ernst-Jan M., Kirpensteijn, Jolle, Mol, Jan A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2016
Soggetti:
Original Research Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4892226/
https://ncbi.nlm.nih.gov/pubmed/27049037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2016.0032
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi